1. Home
  2. Analysis
  3. Prilosec
  4. Emtriva

Prilosec and Emtriva drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Prilosec (omeprazole) and Emtriva (emtricitabine). Common drug interactions include chronic kidney disease among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Prilosec and Emtriva. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.

What is Prilosec?

Prilosec has active ingredients of omeprazole. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 175,285 Prilosec users. Check the latest studies of Prilosec.

What is Emtriva?

Emtriva has active ingredients of emtricitabine. eHealthMe is studying from 2,383 Emtriva users. Check the latest studies of Emtriva.

On Jul, 14, 2026

27 people who take Prilosec and Emtriva together, and have interactions are studied.

Prilosec and Emtriva drug interactions.

What are the common drug interactions of Prilosec and Emtriva, by gender? *:

female:

  1. Chronic kidney disease
  2. Nephrogenic anaemia (anaemia due to kidney disease)
  3. Renal failure (kidney dysfunction)
  4. Renal injury (kidney injury)
  5. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)

male:

  1. Chronic kidney disease
  2. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  3. Immune reconstitution syndrome (immune recovery syndrome)
  4. Osteopenia (a condition where bone mineral density is lower than normal)
  5. Staphylococcal sepsis (blood infection by an infection with staphylococcus bacteria)
  6. Abnormal dreams
  7. Cardiomyopathy (weakening of the heart muscle)
  8. Delusion (a false belief or opinion)
  9. Diabetic coma
  10. Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)

What are the common drug interactions of Prilosec and Emtriva, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Chronic kidney disease
  2. Diabetic coma
  3. Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
  4. Dyspepsia (indigestion)
  5. Herpes virus infection
  6. Hyperglycaemia (high blood sugar)
  7. Nephrogenic anaemia (anaemia due to kidney disease)
  8. Oral candidiasis (fungal infection of mouth)
  9. Renal failure (kidney dysfunction)
  10. Renal injury (kidney injury)

40-49:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Cardiac failure
  4. Emotional distress
  5. Osteoporosis (bones weak and more likely to break)
  6. Pain
  7. Immune reconstitution syndrome (immune recovery syndrome)
  8. Staphylococcal sepsis (blood infection by an infection with staphylococcus bacteria)
  9. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  10. Anxiety

50-59:

  1. Renal failure (kidney dysfunction)
  2. Renal injury (kidney injury)
  3. Seminoma (a germ cell tumour of the testis)
  4. Chronic kidney disease
  5. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  6. Dyspnoea (difficult or laboured respiration)
  7. Fluid overload (too much fluid in the blood)
  8. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  9. Hypertension (high blood pressure)
  10. Nephrogenic anaemia (anaemia due to kidney disease)

60+:

  1. Abnormal sensation in eye
  2. Blindness
  3. Loss of consciousness

What are the existing conditions these people have? *

  1. Hiv Infection: 12 people, 44.44%
  2. Acquired Immunodeficiency Syndrome (disease of the human immune system caused by the human immunodeficiency virus (hiv)): 4 people, 14.81%
  3. Pain: 4 people, 14.81%
  4. High Blood Pressure: 3 people, 11.11%
  5. Fungal Infection: 2 people, 7.41%
  6. Bipolar Disorder (mood disorder): 2 people, 7.41%
  7. Blood Calcium Increased: 2 people, 7.41%
  8. Blood Phosphorus Increased: 2 people, 7.41%
  9. Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 2 people, 7.41%
  10. Diabetes: 2 people, 7.41%

* Approximation only. Some reports may have incomplete information.

Do you take Prilosec and Emtriva?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Prilosec and Emtriva:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Prilosec:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Emtriva:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Prilosec and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Emtriva and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on omeprazole and emtricitabine (the active ingredients of Prilosec and Emtriva, respectively), and Prilosec and Emtriva (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.